Tracheal Stenosis. Other specified diseases of upper respiratory tract
Conditions
Interventions
Intervention 1: Intervention group: drug: capsule containing 15 mg of prednisolon
dose: one capsule/day
time of consumption: 6 months. Intervention 2: Control group: placebo: capsule with no medicine
time of consumption: 6 months.
Treatment - Drugs
Placebo
Intervention group: drug: capsule containing 15 mg of prednisolon
time of consumption: 6 months
Control group: placebo: capsule with no medicine
Sponsors
Vice Chancellor for National research institute of tuberculosis and lung diseases,Dr Massih Daneshva
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: All patients with post intubation tracheal stenosis who are not ideal candidate for airway surgery at the time of first presentation. Exclusion criteria: patients presented with tracheostomy or t-tube; patients presented 6 months after the intubation time; patients younger than 15 years old.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of patients who undergo airway resection;. Timepoint: 6 months following end of intervention. Method of measurement: the number of patients who undergo airway surgery.;The length of resected tracheal segment. Timepoint: whenever the resetion and anastomosis of the trachea is performed. Method of measurement: rigid bronchoscopy, pathology report. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of bronchoscopies. Timepoint: before an airway resection. Method of measurement: counting the number of bronchoscopies before surgery.;The time intervals between bronchoscopic procedures. Timepoint: before an airway resection. Method of measurement: days interval between bronchoscopic procedures. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Behgam Shadmehr
Tracheal Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences
Outcome results
None listed